Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments, announces that it has issued 973 shares to the Company’s employee share ownership trust (the “ESOT”) at at yesterday’s mid-market closing price on AIM of 4.62 pence per share, in order to increase the overall number of issued shares to 145,580,000. The need for this issue was noted in the Company’s circular of 1 May 2013 (the “Circular”) describing proposals for a capital reorganisation, and is needed to increase the overall number to one that is exactly divisible by 10,000. Application has been made for the new ordinary shares to be admitted to trading on AIM and Alternext, and dealings are expected to commence on 5 June 2013.
In addition, certain directors have rounded up certain holdings to the nearest 10,000 by acquiring the number of additional shares set out in the table below. All the shares were purchased from the ESOT at yesterday’s mid-market closing price on AIM of 4.62 pence per share, except the purchase by Inkberrow Limited which was executed in Amsterdam at a price of 6 eurocents per share, and the purchase by Stuart Silcock as executor which was executed in London at a price of 4.8 pence per share. As well as the holdings listed below, Barry Mence is also potential beneficiary under trusts holding 2,000,000 shares, and Stuart Silcock has a separate holding of 950,000 shares.
|Existing Holding||Acquisition||Updated Holding|
|Inkberrow Limited (Note 1)||2,300,820||9,180||2,310,000|
|Maria Teresa Mence (Note 2)||6,688||3,312||10,000|
|Stuart Silcock (Note 3)||76,639||3,361||80,000|
|Stuart Silcock (Note 4)||2,000||8,000||10,000|
- Inkberrow Limited is a company in which Barry Mence is the majority shareholder
- Maria Teresa Mence is spouse of Barry Mence
- Stuart Silcock owns these shares as trustee
- Stuart Silcock has been appointed executor and is a beneficiary of the estate that owns these shares
Further details of the reorganisation can be found in the Company’s announcement dated 2 May 2013, or in the Circular itself which is available on the Company’s website.
|For Further Information Contact:|
|Barry Mence, Chairman||Sopheon plc||+ 44 (0) 1483 685 735|
|Arif Karimjee, CFO||Sopheon plc||+ 44 (0) 1483 685 735|
|Charlotte Stranner / Victoria Bates||finnCap||+ 44 (0) 20 7600 1658|
|Heather Armstrong||Newgate Threadneedle||+ 44 (0) 20 7653 9842|
|Claire Verhagen||Citigate First Financial||+ 31 (0) 205 754 010|
Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands.